{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:38:09Z","timestamp":1772624289738,"version":"3.50.1"},"reference-count":10,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"DOI":"10.25259\/ijdvl_558_2022","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T12:45:03Z","timestamp":1682081103000},"page":"754-756","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intravenous immunoglobulin for the management of Netherton syndrome"],"prefix":"10.25259","volume":"89","author":[{"given":"Shekhar","family":"Neema","sequence":"first","affiliation":[{"name":"Department of Dermatology, AFMC, Pune, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biju","family":"Vasudevan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, AFMC, Pune, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amol","family":"Rathod","sequence":"additional","affiliation":[{"name":"Department of Dermatology, AFMC, Pune, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, AFMC, Pune, Maharashtra, India,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senkadhir","family":"Vendhan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, AFMC, Pune, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Gera","sequence":"additional","affiliation":[{"name":"Department of Dermatology, AFMC, Pune, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"key":"10.25259\/IJDVL_558_2022\/ref-1","first-page":"822","article-title":"Neonatal and infantile erythrodermas","volume":"137","author":"Sarkar","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.25259\/IJDVL_558_2022\/ref-2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000514699","article-title":"Netherton syndrome: Case report and review of the literature","volume":"7","author":"Herz-Ruelas","year":"2021","journal-title":"Skin Appendage Disord"},{"key":"10.25259\/IJDVL_558_2022\/ref-3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13023-018-0956-6","article-title":"Immune cell phenotype and functional defects in Netherton syndrome","volume":"13","author":"Er\u00e4nk\u00f6","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.25259\/IJDVL_558_2022\/ref-4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jamadermatol.2019.4608","article-title":"Treatment of Netherton syndrome with dupilumab","volume":"156","author":"Steuer","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.25259\/IJDVL_558_2022\/ref-5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/jamadermatol.2020.1019","article-title":"Secukinumab therapy for Netherton syndrome","volume":"156","author":"Luchsinger","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.25259\/IJDVL_558_2022\/ref-6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jdcr.2020.01.007","article-title":"Response to low-dose intravenous immunoglobulin in a case of recalcitrant Darier disease","volume":"6","author":"Legrand","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.25259\/IJDVL_558_2022\/ref-7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Com\u00e8l-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.25259\/IJDVL_558_2022\/ref-8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/pde.14318","article-title":"A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome","volume":"37","author":"Zelieskova","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.25259\/IJDVL_558_2022\/ref-9","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1016\/j.anai.2018.09.443","article-title":"The difficult management of three patients with Netherton syndrome","volume":"121","author":"Saenz","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.25259\/IJDVL_558_2022\/ref-10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000525987","article-title":"Treatment experiences with intravenous immunoglobulins, ixekizumab, dupilumab, and anakinra in Netherton syndrome: A case series","author":"Ragamin","year":"2022","journal-title":"Dermatology"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/intravenous-immunoglobulin-for-the-management-of-netherton-syndrome\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/intravenous-immunoglobulin-for-the-management-of-netherton-syndrome\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T04:33:45Z","timestamp":1693197225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/intravenous-immunoglobulin-for-the-management-of-netherton-syndrome\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":10,"alternative-id":["10.25259\/IJDVL_558_2022"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_558_2022","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]},"article-number":"754"}}